leadf
logo-loader

Coronavirus

Add to MyProactive
Health

Empower Clinics KAI Medical Lab to launch FDA-approved...

Its previously announced major contract for ABC-PCR testing in the film and TV industry launching in early...

Tetra Bio-Pharma - Health Tetra Bio-Pharma clears path to human trials of potential...
2 days, 18 hours ago
Todos Medical Ltd. - Health Todos Medical sees its November 2020 sales surge 269%...
2 days, 19 hours ago
Pfizer - Pfizer/BioNTech to deliver 50mln doses of COVID-19 vaccine worldwide this month Health Pfizer/BioNTech to deliver 50mln doses of COVID-19 vaccine...
2 days, 19 hours ago
Pfizer - Coronavirus: UK first country to approve Pfizer/BioNTech vaccine Health Coronavirus: UK first country to approve Pfizer/BioNTech vaccine
3 days, 1 hour ago
AstraZeneca -
4 days, 17 hours ago
covid
4 days, 18 hours ago
AIM ImmunoTech Inc - AIM says first patient dosed with Ampligen in study evaluating it as drug combo to treat patients with cancer and COVID-19
1 week, 3 days ago
covid
1 week, 5 days ago
Todos Medical Ltd. -
2 weeks, 1 day ago
Empower Clinics Inc. -
2 weeks, 2 days ago
Swab held next to a bottle labeled 'COVID-19'
3 weeks, 1 day ago
Co-Diagnostics - Co-Diagnostics says its CoPrimers proved effective in COVID-19 Saliva PCR Tests without sample extraction
3 weeks, 3 days ago
PreveCeutical Medical Inc. - PreveCeutical Medical Inc says it is advancing its coronavirus (COVID-19) Cannabinoid Sol-Gel Program
3 weeks, 4 days ago
Algernon Pharmaceuticals Inc. - Algernon to share interim data from Phase 2b/3 human COVID-19 study of Ifenprodil in December
3 weeks, 5 days ago
covid
4 weeks, 1 day ago
Tetra Bio-Pharma - Tetra Bio-Pharma says ARDS-003 has potential to earn $500M in revenue from royalties, upfront payments by 2026
1 month, 1 day ago
Cameron - Humanigen says first patient dosed in NIH-run ACTIV-5 ‘Big Effect Trial’ evaluating lenzilumab for COVID-19
on 10/30/2020
Algernon Pharmaceuticals Inc. - Algernon Pharmaceuticals Inc wins Data and Safety Monitoring Board approval to continue its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19
on 10/30/2020
XPhyto Therapeutics Corp. - XPhyto touts rapid RT-PCR test for point-of-care COVID-19 detection
on 10/28/2020